InflaRx NV (IFRX)
0.87
-0.02
(-2.78%)
USD |
NASDAQ |
Feb 09, 14:42
InflaRx Market Cap : 58.94M for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CDT Equity, Inc. | 1.906M |
| LENZ Therapeutics, Inc. | 442.75M |
| Liminatus Pharma, Inc. | 44.12M |
| Oruka Therapeutics, Inc. | 1.600B |
| Maze Therapeutics, Inc. | 2.243B |
Market Cap Related Metrics
| PS Ratio | 268.81 |
| PEG Ratio | -0.1434 |
| Price to Book Value | 1.106 |
| Price | 0.87 |
| Earnings Yield | -105.4% |
| PEGY Ratio | -0.1434 |